Table 4.
Nab-Paclitaxel Group | Best Supportive Care | |
---|---|---|
Cardiac | 3 | 6 |
Dysphagia | 1 | 9 |
Neutropenia | 5 | 0 |
Thrombocytopenia | 9 | 0 |
Alopecia | 21 | 0 |
Fatigue | 15 | 9 |
Hypersensitivity | 1 | 0 |
*Regarding neutropenia and thrombocytopenia the numbers reflect the number of patients that presented these adverse effects and not the number of subcutaneous injections